Archives
-
ML365: TASK1 Workflows for Translational Research
2026-09-17
ML365 combines potent TASK1 inhibition with practical utility across electrophysiology, neuroinflammation, and cardiopulmonary models. This guide shows how to connect channel engagement to downstream phenotypes while controlling assay, formulation, and mGluR5-related confounders.
-
HMGB1 Proteomics for Early Diabetic Nephropathy
2026-09-17
Peng et al. combined quantitative serum proteomics with Mfuzz clustering and weighted gene co-expression network analysis to identify proteins associated with diabetic nephropathy progression. HMGB1 showed the strongest promise among five candidates and was further supported by high-glucose cell and animal experiments, although independent clinical validation is still required.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-09-16
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, frozen or paraffin IHC, flow cytometry, and ELISA. It should not be used as a general secondary for non-goat primaries, and assay-specific titration and controls are required because no directly matched paper evidence is available here.
-
Phalloidin (B7678): F-Actin Workflow Guide
2026-09-16
Phalloidin (B7678) provides high-affinity stabilization of filamentous actin for endpoint cytoskeleton visualization in fixed, permeabilized samples and cell-free assays. It is not appropriate for live-cell imaging or experiments that require reversible actin binding and normal cytoskeletal dynamics.
-
Real-Time Tracking of Nanoparticulate Vaccines in Lymph Node
2026-09-15
Misra et al. introduce an abdominal window-chamber platform for observing nanoparticle drainage and residence in inguinal lymph nodes of live mice after intramuscular administration. By pairing luciferase mRNA bioluminescence with indocyanine green fluorescence, the study distinguishes delivery-associated behavior from mRNA translation and shows that ionizable lipid composition can alter lymph-node expression.
-
Cyanine 3 Tyramide in Comparative Neurobiology
2026-09-15
A translational framework for using Cyanine 3 Tyramide and Tyramide Signal Amplification to resolve conserved gene-expression architecture across mammalian claustrum subdivisions.
-
BET Inhibition in HPV-16 HNSCC: Heterogeneous Responses
2026-09-14
This preprint examines how BET protein inhibition affects HPV-16-associated head and neck squamous cell carcinoma, with emphasis on tumors containing integrated viral genomes. Its central contribution is the demonstration that BET inhibition produces heterogeneous viral transcriptional responses while converging on selected cellular programs, including c-Myc and E2F suppression, CDKN1A induction, G1 arrest, and apoptosis.
-
Tamoxifen in Recurrent Airway Models
2026-09-14
Tamoxifen is more than a gene-switch reagent: it is a biologically active selective estrogen receptor modulator that can shape experimental interpretation. This article connects its inducible genetics applications with the longitudinal immune-assay strategy revealed by a 2025 Nature study of recurrent airway inflammation.
-
AM 281: Practical CB1 Antagonism Workflows
2026-09-13
AM 281 enables selective interrogation of CB1 activity across receptor, astrocyte, TBI, and cognition-focused assays. This workflow-oriented guide connects receptor pharmacology with GLT-1, CREB, and behavioral readouts while emphasizing formulation control and experimental safeguards.
-
N-MYC–eIF4G1 Axis in inv(16) AML
2026-09-12
Peramangalam and colleagues identify an N-MYC enhancer and the translation-initiation factor eIF4G1 as components of a survival pathway in inv(16) acute myeloid leukemia. Their integrated use of transcriptomic analysis, enhancer studies, primary leukemia models, and patient-derived xenografts supports the N-MYC/eIF4G1 axis as a mechanistic vulnerability, while also defining important limits for therapeutic translation.
-
Aucubin, NRF2, and HIPK2 in Doxorubicin Cardiotoxicity
2026-09-11
A 2024 Phytomedicine study identifies aucubin as a potential cardioprotective agent that coordinates NRF2 and HIPK2 signaling to reduce oxidative stress, autophagy disruption, and apoptosis during Doxorubicin exposure. Its central translational finding is that aucubin protected cardiac tissue in experimental models without measurably weakening Doxorubicin activity against MCF-7 and HepG2 cells in vitro.
-
Lambda Protein Phosphatase for BMAL1 Studies
2026-09-11
Use Lambda Protein Phosphatase to distinguish phosphorylation-dependent changes in BMAL1 abundance, antibody reactivity, and phase-separation behavior. This practical workflow combines paired dephosphorylation controls with circadian condensate assays, while highlighting inhibitor management and assay-stop strategies.
-
MALAT1, TDP-43, and Sequence-Specific Splicing
2026-09-10
A 2025 Nucleic Acids Research study shows that MALAT1 regulates alternative splicing through sequence-dependent RNA–RNA contacts and cooperative RNA–protein assemblies. Its analysis of MALAT1–TDP-43–SAT1 and MALAT1–CSTF2–PPFIA3 interactions provides a mechanistic framework for understanding how abundant non-coding RNAs influence transcript processing.
-
Cy3 RNA Probes: From RNAi Mechanism to Translation
2026-09-10
RNAi delivery studies reveal why localization and transcript-level validation matter alongside phenotype. This thought-leadership guide connects those mechanistic needs with tunable fluorescent probe synthesis using the HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit for in situ hybridization and Northern blot workflows.
-
Fasudil (HA-1077) HCl for Reliable Cell Assays
2026-09-09
This scenario-based guide explains how Fasudil (HA-1077) HCl, SKU A5734, can improve the design and interpretation of ROCK-pathway cell assays. It connects mechanism, formulation, dose selection, orthogonal readouts, storage, and vendor evaluation to practical laboratory decisions.